Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel
Gili Regev‐Yochay, Sharon Amit, Moriah Bergwerk, et al.
The Lancet Regional Health - Europe (2021) Vol. 7, pp. 100150-100150
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Moriah Bergwerk, Tal Gonen, Yaniv Lustig, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 16, pp. 1474-1484
Open Access | Times Cited: 1364
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
E G Levin, Yaniv Lustig, Carmit Cohen, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 1083
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Emma K. Accorsi, Amadea Britton, Katherine E. Fleming-Dutra, et al.
JAMA (2022) Vol. 327, Iss. 7, pp. 639-639
Open Access | Times Cited: 643
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 475-484
Open Access | Times Cited: 530
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 57-65
Open Access | Times Cited: 305
The changing epidemiology of SARS-CoV-2
Katia Koelle, Michael A. Martin, Rustom Antia, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1116-1121
Open Access | Times Cited: 257
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Karin Bok, Sandra Sitar, Barney S. Graham, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1636-1651
Open Access | Times Cited: 230
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 151
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study
Eric J. Haas, John M. McLaughlin, Farid Khan, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 3, pp. 357-366
Open Access | Times Cited: 120
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 81
Identifying and Alleviating Bias Due to Differential Depletion of Susceptible People in Postmarketing Evaluations of COVID-19 Vaccines
Rebecca Kahn, Stephanie J. Schrag, Jennifer R. Verani, et al.
American Journal of Epidemiology (2022) Vol. 191, Iss. 5, pp. 800-811
Open Access | Times Cited: 72
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Anu Haveri, Nina Ekström, Anna Solastie, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 3202-3213
Open Access | Times Cited: 90
Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies
Chia Siang Kow, Syed Shahzad Hasan
Inflammopharmacology (2021) Vol. 29, Iss. 4, pp. 1075-1090
Open Access | Times Cited: 77
Interpreting vaccine efficacy trial results for infection and transmission
Marc Lipsitch, Rebecca Kahn
Vaccine (2021) Vol. 39, Iss. 30, pp. 4082-4088
Open Access | Times Cited: 75
Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors
Ithai Waldhorn, Roy Holland, Tal Goshen‐Lago, et al.
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2430-2435
Open Access | Times Cited: 57
Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational Study
Maylis Layan, Mayan Gilboa, Tal Gonen, et al.
American Journal of Epidemiology (2022) Vol. 191, Iss. 7, pp. 1224-1234
Open Access | Times Cited: 51
SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron’s impact in South African population cohorts
Kaiyuan Sun, Stefano Tempia, Jackie Kleynhans, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 659
Open Access | Times Cited: 51
Memory CD8+ T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination
Nadia Brasu, Ines Elia, Valentina Russo, et al.
Nature Immunology (2022) Vol. 23, Iss. 10, pp. 1445-1456
Open Access | Times Cited: 47
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 43
4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC
Gili Regev‐Yochay, Tal Gonen, Mayan Gilboa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 40
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
Toon Braeye, Lucy Catteau, Ruben Brondeel, et al.
Vaccine (2023) Vol. 41, Iss. 20, pp. 3292-3300
Open Access | Times Cited: 37
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 49
A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines
Xiao‐Feng He, Jiao Su, Yunan Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers
Gregory Joseph, John Barnes, Eduardo Azziz‐Baumgartner, et al.
JAMA (2022) Vol. 328, Iss. 15, pp. 1523-1523
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top